Page last updated: 2024-11-04

terfenadine and Myocardial Infarction

terfenadine has been researched along with Myocardial Infarction in 2 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adebesin, AM1
Wesser, T1
Vijaykumar, J1
Konkel, A1
Paudyal, MP1
Lossie, J1
Zhu, C1
Westphal, C1
Puli, N1
Fischer, R1
Schunck, WH1
Falck, JR1
Gunawardena, MD1
Weerasinghe, A1
Herath, J1
Amarasena, N1

Other Studies

2 other studies available for terfenadine and Myocardial Infarction

ArticleYear
Development of Robust 17(
    Journal of medicinal chemistry, 2019, 11-27, Volume: 62, Issue:22

    Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Dose-Response Relationship

2019
Myocardial infarction associated with eosinophilia and plasma extravasation at multiple sites. A variant of Kounis syndrome.
    BMJ case reports, 2015, Jan-21, Volume: 2015

    Topics: Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Eosinophilia; Humans; Hypersensitivity, Immed

2015